Media Center
Newsroom
Newsroom
Press Release

SEOUL VIOSYS Takes Strong Action against the Theft of its Ultraviolet LED Technology.

2016. 08. 11

 SEOUL VIOSYS Takes Strong Action against the Theft of its Ultraviolet LED Technology.

 

- SEOUL VIOSYS has filed a lawsuit against a US company for the infringement of its patents, including the manufacturing technology of the ultraviolet LED chip, packaging and bug trap device
- SEOUL VIOSYS attempts to protect the ‘violeds’ technology which lures 13 times more Zika virus mosquitoes, and 9 times more malaria mosquitoes
- Leading the UV market by spreading UV LED through the protection of its patented ‘violeds’ technology and mass production.

 

SEOUL VIOSYS, a world class UV LED solution company (www.seoulviosys.com), announced that it has filed a lawsuit with the Federal District Court of Southern New York, US on August 8 against P3 International, a US manufacturer of home electronics products who sells their products through large retail shops such as WalMart, on the grounds that the company has infringed SEOUL VIOSYS’s UV LED mosquito trap device MosClean’s patented technology.

 

Last month, SEOUL VIOSYS won the patent lawsuit filed against Shalon, a manufacturer of UV LED curing systems, and made the company suspend the sales of the patent infringing product in addition to receiving damage compensation and royalty for the use of the patent. Following this lawsuit on the infringement of its UV LED curing system, SEOUL VIOSYS filed a lawsuit regarding the infringement of its UV LED mosquito trap device technology, thereby showing that it would take strong action against any company which infringes on its patented technologies.

 

What is at issue the patented technology in this lawsuit that includes technologies for the manufacturing of the UV LED mosquito trap, such as the manufacturing and packaging of UV LED chips optimized to lure Zika virus mosquitoes, and the manufacturing of the insect trap engine.

 

SEOUL VIOSYS began to develop the UV LED mosquito trap under the advice of Professor Lee, Dongkyu, an authority in Korea on mosquitoes, by focusing on the premise that mosquitoes are lured to UV rays. After long research and development, the technology called “violeds” was finally developed and was commercialized as Mosclean, which is the best at luring mosquitoes using violeds technology.

 

 

 

                                              


As shown in performance tests conducted in the US, Vietnam, Indonesia and Korea, Mosclean has proven to be 4 times more effective in catching mosquitoes than the standard mosquito trap. In addition, Professor Kohler, a world authority on entomology in the US, proved that it is able to lure 13 times more Zika virus mosquitoes and 7 times more malaria mosquitoes than the standard mosquito traps of the US CDC.

 

 

 

                                                                          

 


The World Health Organization (WHO) indicated that mosquitoes are the most hazardous animals to humans, and that more than 720,000 people a year around the world die due to diseases caused by mosquitoes. There are more than 200 million cases of disease caused by mosquitoes. In particular, the Zika virus, which is spread through mosquitoes, is found to be the main cause of microcephaly in new born babies. However, more than 80 of infected patients do not know that they are infected and it can be transmitted through sexual relations.

 

Since it is known that this technology has the ability to capture at max,13 times more Adedes aegypti (Zika) and 9 times more Anopheles sierroides (or the stained wing mosquito) than standard traps, more and more companies are stealing the patented technologies of SEOUL VIOSYS. This is why patent lawsuits have been filed against them by SEOUL VIOSYS. For the protection and expansion of violeds technology, SEOUL VIOSYS plans to continue filing lawsuits against infringing companies.

 

Mr. Kang, TaeWoong, president of SEOUL VIOSYS has said that “We have put a lot of energy into R&D for the development of UV LED technologies for the past 15 years, and as a result, for the first time in the world we have developed the ‘violeds’ technology. For the mass production of UV LED devices, we received approval the US Department of Defense and Foreigner Investment Committee, and increased production facilities in SETi, which is our subsidiary in the US, to expand product production. He also said that “Just as Nichia is the representative company of white and blue LED production, we will be the company representing UV LED. We will put more effort into protecting violed patented technologies and applied products, and will expand the products at a reasonable price in order to help people around the world achieve a healthier life, and cleaner and comfortable living conditions.”


* About violeds?
violeds is an advanced and clean technology realized by the collaboration of UV LED solution company SEOUL VIOSYS and deep UV leader SETI to provide a clean and safe global environment. Not all LED are violeds. It is incorrect to think of UVLED as a lighting bulb. The UV LED technology is distinguished other LEDs in that it is not for lighting that the human eye sees but has properties that affect the nature of physics in polymers, biological both health benefits to humans and disinfection of harmful bacteria.The technology can be applied to bio-technology equipment and medical diagnosis equipment as well as skin and other medical treatment.

 

* About SEOUL VIOSYS.
SEOUL VIOSYS is a company specializing in UV LED and Blue LED Chip manufacturing, which Officers and employees Seoul Semiconductor, LED specialist, founded, invested in, and operate. After its establishment in 2002, the company has focused on UV applications and is contributing the expanded providing of UV LED. SEOUL VIOSYS is continuously committing R&D efforts to develop electronic devices. As of June 2015, SEOUL VIOSYS total assets are worth USD 314 million, and the company’s 700 employees are committed to the development and manufacturing of UV LED products